News

Researchers have developed a gene therapy that rescues cilia defects to treat a rare disease that causes blindness in early childhood.

A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses has begun enrolling adult volunteers.

A new study has identified an association between influenza vaccine and a reduced risk of stroke. The research is published in the journal Neurology.

According to two clinical trials, boosting vitamin D levels in adults during the SARS-CoV-2 pandemic was not associated with protection against respiratory tract infections or COVID-19.

A new strategy for vaccinating against HIV, using adjuvants, has shown promise in a pre-clinical research study.

A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published in the American Heart Association’s flagship journal Circulation.

Researchers have built the most complex and well-defined synthetic microbiome by creating a community of over 100 bacterial species that was successfully transplanted into mice.

Research into how the blood protein vitronectin changes when under pressure – such as when it passes through the blood vessels at the back of the eye – could unlock the mechanism of macular degeneration.

Researchers have shown that a converted form of huntingtin, resistant to developing cleavages known to be the cause of Huntington’s disease, alleviated the disease’s symptoms and maintained the functions of normal huntingtin.

New research has found that hydroquinine, a compound found in the bark of trees and used as an anti-malarial, also has bacterial killing activity.